GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clicks Group Ltd (JSE:CLS) » Definitions » Altman Z-Score

Clicks Group (JSE:CLS) Altman Z-Score : 6.13 (As of May. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Clicks Group Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 6.13 is strong.

Clicks Group has a Altman Z-Score of 6.13, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Clicks Group's Altman Z-Score or its related term are showing as below:

JSE:CLS' s Altman Z-Score Range Over the Past 10 Years
Min: 5.68   Med: 6.22   Max: 6.75
Current: 6.13

During the past 13 years, Clicks Group's highest Altman Z-Score was 6.75. The lowest was 5.68. And the median was 6.22.


Clicks Group Altman Z-Score Historical Data

The historical data trend for Clicks Group's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clicks Group Altman Z-Score Chart

Clicks Group Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.68 6.37 6.40 6.61 5.92

Clicks Group Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.61 - 5.92 -

Competitive Comparison of Clicks Group's Altman Z-Score

For the Pharmaceutical Retailers subindustry, Clicks Group's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clicks Group's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Clicks Group's Altman Z-Score falls into.



Clicks Group Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Clicks Group's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.0543+1.4*0+3.3*0.1945+0.6*5.3987+1.0*2.1866
=6.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Aug. 2023:
Total Assets was R19,035 Mil.
Total Current Assets was R11,834 Mil.
Total Current Liabilities was R10,800 Mil.
Retained Earnings was R0 Mil.
Pre-Tax Income was R3,471 Mil.
Interest Expense was R-232 Mil.
Revenue was R41,622 Mil.
Market Cap (Today) was R70,562 Mil.
Total Liabilities was R13,070 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(11833.745 - 10799.648)/19034.854
=0.0543

X2=Retained Earnings/Total Assets
=0/19034.854
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(3471.105 - -231.58)/19034.854
=0.1945

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=70561.715/13070.04
=5.3987

X5=Revenue/Total Assets
=41621.681/19034.854
=2.1866

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Clicks Group has a Altman Z-Score of 6.13 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Clicks Group  (JSE:CLS) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Clicks Group Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Clicks Group's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Clicks Group (JSE:CLS) Business Description

Traded in Other Exchanges
Address
Cnr Searle and Pontac Streets, PO Box 5142, Cape Town, ZAF, 8001
Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company primarily operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle- to upper-income consumers. Clicks' business strategy focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, GNC, and claire's. Clicks uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market.